Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy
Aging Cell · 2026-08 · 25 (8)
DOI: 10.1111/acel.70672 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging Cell, online erschienen am 17.08.2026. Verfasst von Astrid Sodomaco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Signalling Laboratory, Anatomy Center, Department of Biomedical Sciences (DIBINEM), University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Rejuvenation, Cell- and Tissue-Based Therapy, Translational Research, Biomedical. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione giovani diabetici AGD Bologna.
Abstract (Originalsprache)
Cell therapies represent a promising frontier in modern medicine. Mesenchymal stromal cells (MSCs) constitute a valuable source due to their minimal ethical concerns, low immunogenicity, negligible tumorigenicity in vivo, and robust paracrine activity mediated by the secretion of anti‐inflammatory and angiogenic factors. Despite these advantages, MSCs undergo rapid replicative senescence accompanied by a progressive loss of stemness markers and functional potency. In this context, cellular rejuvenation has been emerging as a pivotal strategy to restore their original biological features. These approaches aim to modulate the hallmarks of aging; as these processes are highly interconnected, multiple and complementary targets have been proposed. This review aims to discuss and analyze the main rejuvenation strategies reported in the literature for MSCs, with particular attention to approaches that can enhance their functionality and translational potential. In this context, the review focuses on five key categories of interventions: epigenetic modifications, metabolic reprogramming, modulation of cellular senescence, telomere biology, and extracellular vesicles. These strategies represent the fundamental axes through which cellular aging can be counteracted and the efficacy of cell‐based therapies improved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cellular Signalling Laboratory, Anatomy Center, Department of Biomedical Sciences (DIBINEM), University of Bologna, Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
ORCID-Profile: Irene Bernardi, Francesca Paris, Lucia Manzoli, Stefano Ratti
Förderung
- Associazione giovani diabetici AGD Bologna
Zitieren
APA
Sodomaco, A., Bernardi, I., Rambaldi, A., Lombardi, P., Rossi, M., Paris, F., Manzoli, L., Ratti, S., & Alviano, F. (2026). Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy. Aging Cell, 25(8). https://doi.org/10.1111/acel.70672
Vancouver
Sodomaco A, Bernardi I, Rambaldi A, Lombardi P, Rossi M, Paris F, et al. Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy. Aging Cell. 2026;25(8). doi:10.1111/acel.70672
BibTeX
@article{Sodomaco2026,
author = {Sodomaco, Astrid and Bernardi, Irene and Rambaldi, Aretha and Lombardi, Pierluigi and Rossi, Maura and Paris, Francesca and Manzoli, Lucia and Ratti, Stefano and Alviano, Francesco},
title = {Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {8},
doi = {10.1111/acel.70672}
}
EUVIMED